1 |
Kasprzak, K.S., Sunderman, F.W. Jr. & Salnikow, K. Nickel carcinogenesis. Mutat. Res. 533, 67-97 (2003)
DOI
|
2 |
Evans, R.M., Davies, P.J. & Costa, M. Video timelapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells. Cancer Res. 42, 2729-2735 (1982)
|
3 |
Kasprzak, K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32, 958-967 (2002)
DOI
ScienceOn
|
4 |
Lee, Y.W. et al. Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol. Cell. Biol. 15, 2547-2557 (1995)
DOI
|
5 |
Cheng R.Y. et al. Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel (II). Toxicol. Appl. Pharmacol. 191, 22-39 (2003)
DOI
ScienceOn
|
6 |
Galarraga, J. et al. Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism. Metab. Brain. Dis. 1, 279-291 (1986)
DOI
ScienceOn
|
7 |
Zhao, J. et al. Nickel-induced 1, 4-alpha-glucan branching enzyme 1 up-regulation via the hypoxic signaling pathway. Toxicol. Appl. Pharmacol. 196, 404-409 (2004)
DOI
PUBMED
ScienceOn
|
8 |
Salnikow et al. Nickel induced transfiormation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis. 20, 1819-1823 (1999)
DOI
ScienceOn
|
9 |
Salnikow et al. Carcinogenic metals induce hypoxiainducible factor-stimulated transcription by reactive oxygen species-independent mechanism. Cancer Res. 60, 3375-3378 (2000)
|
10 |
Andrew et al. Nickel requires hypoxia-inducible factor- , not redox signaling to induce plasminogen activator inhibitor-1. Am. J. Physiol. Lung Cell Mol. Physiol. 281, 607-615 (2001)
|
11 |
Doll, R., Mathews, J.D. & Morgan, L.G. Cancers of the lung and nasal sinuses in nickel workers: a reassessment of the period of risk. Br. J. Ind. Med. 34, 102-105 (1977)
|
12 |
Costa, M. & Mollenhauer, H.H. Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. Science. 209, 515-517 (1980)
DOI
PUBMED
|
13 |
Gunshin, H. et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388, 482-488 (1997)
DOI
ScienceOn
|
14 |
Sunderman, F.W. Jr. Carcinogenicity of nickel compounds in animals. IARC. Sci. Publ. 53, 127-142 (1984)
|
15 |
Asmuss, M., Mullenders, L.H., Eker, A. & Hartwig, A. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis. 21, 2097-2104 (2000)
DOI
ScienceOn
|
16 |
Costa, M. & Mollenhauer, H.H. Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue culture. Cancer Res. 40, 2688-2694 (1980)
|
17 |
Costa, M. et al. The role of oxidative stress in nickel and chromate genotoxicity. Mol. Cell Biochem. 234- 235(1-2), 265-275 (2002)
|
18 |
Bal, W., Schwerdtle, T. & Hartwig, A. Mechanism of nickel assault on the zinc finger of DNA repair protein XPA. Chem. Res. Toxicol. 16, 242-248 (2003)
DOI
ScienceOn
|
19 |
Chen, C.Y., Wang, Y.F., Huang, W.R. & Huang, Y.T. Nickel induces oxidative stress and genotoxicity in human lymphocytes. Toxicol. Appl. Pharmacol. 189, 153-159 (2003)
DOI
ScienceOn
|
20 |
Fletcher, G.G., Rossetto, F.E., Turnbull, J.D. & Nieboer, E. Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds. Environ. Health Perspect. 102, 69-79 (1994)
DOI
|
21 |
Smith, M.L. et al. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell Biol. May. 20(10), 3705-3714 (2000)
DOI
ScienceOn
|
22 |
O'Brien, T.J., Ceryak, S. & Patierno, S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res. 533, 3-36 (2003)
DOI
|
23 |
Salnikow, K. & Costa, M. Epigenetic mechanisms of nickel carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 19, 307-318 (2000)
|
24 |
Warburg, O. On respiratory impairment in cancer cells. Science. 124, 269-270 (1956)
|
25 |
Costa, M., Simmons-Hansen, J., Bedrossian, C.W., Bonura, J. & Caprioli, R.M. Phagocytosis, cellular distribution, and carcinogenic activity of particulate nickel compounds in tissue culture. Cancer Res. 41, 2868-2876 (1981)
|
26 |
Tallkvist, J. & Tjalve, H. Transport of nickel across monolayers of human intestinal Caco-2 cells. Toxicol Appl. Pharmacol. 151, 117-122 (1998)
DOI
ScienceOn
|
27 |
Azula, F.J., Alonso, R., Marino, A., Trueba, M. & Macarulla, J.M. impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets. Am. J. Physiol. 265, 1681- 1688 (1993)
DOI
|
28 |
Higinbotham, K.G. et al. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/ iron are consistent with oxidative damage to DNA. Cancer Res. 52, 4747-4751 (1992)
|
29 |
Conway, K. & Costa, M. Nonrandom chromosomal alterations in nickel-transformed Chinese hamster embryo cells. Cancer Res. 49, 6032-6038 (1989)
|
30 |
Kasprzak, K.S., Gabryel, P. & Jarczewska, K. Carcinogenicity of nickel (II) hydroxides and nickel (II) sulfate in Wistar rats and its relation to the in vitro dissolution rates. Carcinogenesis. 4, 275-279 (1983)
DOI
ScienceOn
|
31 |
Kawanishi, S. et al. Oxidative DNA damage in cultured cells and rat lungs by carcinogenic nickel compounds. Free Radic. Biol. Med. 31, 108-116 (2001)
DOI
ScienceOn
|
32 |
Oller, A.R., Costa, M. & Oberdorster, G. Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol. 143, 152-166 (1997)
DOI
ScienceOn
|
33 |
Bao, Y., Kishnani, P., Wu, J.Y. & Chen, Y.T. Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogenbranching enzyme gene. J. Clin. Invest. 97, 941-948 (1996)
DOI
ScienceOn
|
34 |
International Agency for Research on Cancer, IARC Monographs on the evaluation of Carcinogenic Risks to Humans, vol. 49, chromium, Nickel and Welding, IARC Scientific Publications, Lyon, 257-445 (1990)
|
35 |
Kuehn, K., Fraser, C.B. & Sunderman, F.W. Jr. Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro. Carcinogenesis. 3, 321-326 (1982)
DOI
ScienceOn
|
36 |
Lechner, J.F., Tokiwa, T., McClendon, I.A. & Haugen, A. Effects of nickel sulfate on growth and differentiation of normal human bronchial epithelial cells. Carcinogenesis. 5, 1697-1703 (1984)
DOI
ScienceOn
|
37 |
Ward, T.L. et al. Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mamm. Genome. 15, 570-577 (2004)
|
38 |
Su, A.I. et al. Large-Scale analysis of the human and mouse transcriptomes. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. U.S.A. 99, 4465-4470 (2002)
DOI
ScienceOn
|
39 |
Costa, M. & Heck, J.D. Perspectives on the mechanism of nickel carcinogenesis. Adv Inorg Biochem. 6, 285-309 (1984)
|
40 |
Refsvik, T. & Andreassen, T. Surface binding and uptake of nickel (II) in human epithelial kidney cells: modulation by ionomycin, nicardipine and metals. Carcinogenesis. 16, 1107-1112 (1995)
DOI
ScienceOn
|
41 |
Salnikow et al. The Involvement of Hypoxia-inducible transcription factor-1-dependent pathway in Nickel carcinogenesis. Cancer Reserch. 63, 3524-3530 (2003)
|
42 |
Foulkes, E.C. & McMullen, D.M. On the mechanism of nickel absorption in the rat jejunum. Toxicology. 38, 35-42 (1986)
DOI
ScienceOn
|
43 |
Klein, C.B. et al. Senescence of nickel-transformed cells by an X chromosome: possible epigenetic control. Science. 251, 796-799 (1991)
DOI
PUBMED
|
44 |
Seo, Y.R. & Jung, H.J. The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER). Exp. Mol. Med. 36, 505-509 (2004)
DOI
ScienceOn
|
45 |
Haber, L.T. et al. Hazard identification and dose response of inhaled nickel-soluble salts. Regul. Toxicol. Pharmacol. 210-230 (2000)
|